|
CBX2 expression profile based on
|
Staaf J, Häkkinen J, Hegardt C, et al. RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer. NPJ Breast Cancer. 2022;8(1):94. Published 2022 Aug 16. doi:10.1038/s41523-022-00465-3
| Comparison | Statistical significance |
| ER negative-vs-ER positive | 5.43057540702852E-05
|
|
Staaf J, Häkkinen J, Hegardt C, et al. RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer. NPJ Breast Cancer. 2022;8(1):94. Published 2022 Aug 16. doi:10.1038/s41523-022-00465-3
| Comparison | Statistical significance |
| HER2 Negative-vs-HER2 Positive | 9.483201E-02 |
|
Staaf J, Häkkinen J, Hegardt C, et al. RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer. NPJ Breast Cancer. 2022;8(1):94. Published 2022 Aug 16. doi:10.1038/s41523-022-00465-3
| Comparison | Statistical significance |
| PR Negative-vs-PR Positive | 2.178628E-04 |
|
Staaf J, Häkkinen J, Hegardt C, et al. RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer. NPJ Breast Cancer. 2022;8(1):94. Published 2022 Aug 16. doi:10.1038/s41523-022-00465-3
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Low-vs-Intermediate |
1.415487E-02 |
| Low-vs-High |
5.910364754038E-05 |
| Intermediate-vs-High |
6.053233E-02 |
|
|
Staaf J, Häkkinen J, Hegardt C, et al. RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer. NPJ Breast Cancer. 2022;8(1):94. Published 2022 Aug 16. doi:10.1038/s41523-022-00465-3
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Low-vs-Intermediate |
9.468153E-01 |
| Low-vs-High |
2.68923404349491E-06 |
| Intermediate-vs-High |
7.65435584410645E-06 |
|
|
Staaf J, Häkkinen J, Hegardt C, et al. RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer. NPJ Breast Cancer. 2022;8(1):94. Published 2022 Aug 16. doi:10.1038/s41523-022-00465-3
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| T1-vs-T2 |
9.317552E-01 |
| T1-vs-T3 |
3.559525E-01 |
| T2-vs-T3 |
3.889714E-01 |
|
|
Staaf J, Häkkinen J, Hegardt C, et al. RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer. NPJ Breast Cancer. 2022;8(1):94. Published 2022 Aug 16. doi:10.1038/s41523-022-00465-3
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal like-vs-LumA |
4.237454E-01 |
| Normal like-vs-LumB |
6.137297E-01 |
| Normal like-vs-HER2 enriched |
4.728963E-03 |
| Normal like-vs-Basal like |
4.462519E-04 |
| LumA-vs-LumB |
2.465019E-01 |
| LumA-vs-HER2 enriched |
3.876764E-03 |
| LumA-vs-Basal like |
3.560308E-04 |
| LumB-vs-HER2 enriched |
5.674174E-03 |
| LumB-vs-Basal like |
5.400363E-04 |
| HER2 enriched-vs-Basal like |
9.495983E-01 |
|
|
Staaf J, Häkkinen J, Hegardt C, et al. RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer. NPJ Breast Cancer. 2022;8(1):94. Published 2022 Aug 16. doi:10.1038/s41523-022-00465-3
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Luminal A-vs-Luminal B |
7.641318E-02 |
| Luminal A-vs-HER2 |
4.085503E-02 |
| Luminal A-vs-Basal |
8.82183022643811E-05 |
| Luminal B-vs-HER2 |
6.145877E-02 |
| Luminal B-vs-Basal |
3.289123E-04 |
| HER2-vs-Basal |
7.013993E-01 |
|
|
